|
|
||||||||
1 Department of Endocrinology and Metabolism, Institute for Adult Diseases, Asahi Life Foundation, Tokyo 160-0023; 2 Department of Health Science, Department of Biostatistics, Kyoto University School of Public Health, Kyoto 606-8501; and 3 Third Department of Internal Medicine, Nihon University, Tokyo 173-8610, Japan
To characterize the "portal signal" in
a nonsteady hyperglycemic state, the kinetic relationship between net
hepatic glucose balance (NHGB) and either hepatic glucose load (HGL) or
plasma insulin level was determined during glucose infusion using a
catheter technique in 36 conscious dogs. Glucose was infused
intraportally (Po group) and peripherally (Pe group) at 39, 56, and 83 µmol · kg
1 · min
1
over 2 h. There was a linear relationship between mean NHGB and either mean HGL or plasma insulin levels at each rate in either delivery (HGL: Po r = 0.99, Pe r = 0.95; insulin: Po r = 99, Pe r = 0.79).
The threshold levels for net hepatic glucose uptake were 3.8 and 11.7 mmol/l for plasma glucose and 65 and 392 pmol/l for plasma insulin,
respectively. The slope of the regression line against the abscissa was
four times larger in portal than in peripheral delivery (HGL: Po 0.20 vs. Pe 0.05, P < 0.05; insulin: Po 0.19 vs. Pe 0.04, P < 0.05). These results suggest that the portal
signal overrules the threshold of glucose for hepatic uptake by
increasing hepatic extraction rate in a nonsteady hyperglycemic state.
glucose delivery route; hepatic glucose load; insulin dependency; hepatic glucose uptake
This article has been cited by other articles:
![]() |
K. M. S. Johnson, D. S. Edgerton, T. Rodewald, M. Scott, B. Farmer, D. Neal, and A. D. Cherrington Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E380 - E384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukaya, A. Mizuno, H. Arai, K. Muto, T. Uebanso, K. Matsuo, H. Yamamoto, Y. Taketani, T. Doi, and E. Takeda Mechanism of rapid-phase insulin response to elevation of portal glucose concentration Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E515 - E522. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ogihara, W. Kawamura, K. Kasuga, Y. Hayashi, H. Arakawa, and M. Kikuchi Characterization of the portal signal during 24-h glucose delivery in unrestrained, conscious rats Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E932 - E940. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Moore, S. Cardin, D. S. Edgerton, B. Farmer, D. W. Neal, M. Lautz, and A. D. Cherrington Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E226 - E233. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Moore, M. J. Burish, B. Farmer, D. W. Neal, C. Pan, and A. D. Cherrington Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E845 - E853. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |